News
7d
24/7 Wall St. on MSNPrediction: 1 Biotech Stock That Could Surpass Pfizer by 2030Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
Financially, CRISPR has $1.9 billion in cash and no debt ... indications that allow it to surpass Pfizer’s drug discovery impact by 2030, helping reshape biotechnology with precision medicine.
The "Shale Gas - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030)" report has been added to ResearchAndMarkets.com's offering.The Shale Gas Market size in terms of ...
The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, ...
According to the Journal, Netflix executives believe they can grow global subscribers from slightly over 301 million to 410 million by 2030, while doubling revenue from $39 billion in 2024 and ...
A Wall Street Journal article had anonymous sources saying that Netflix's goal over the next five years is to double revenue and more than double its market cap to $1 trillion, which would put the ...
Management's next challenge is for Netflix to join an exclusive club of stocks by surpassing $1 trillion in market cap ... 301 million to 410 million by 2030, while doubling revenue from $39 ...
The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, reaching US$3.13 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results